지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한정신약물학회 Clinical Psychopharmacology and Neuroscience Clinical Psychopharmacology and Neuroscience 제15권 제3호
- 발행연도
- 2017.8
- 수록면
- 288 - 291 (4page)
- DOI
- https://doi.org/10.9758/cpn.2017.15.3.288
이용수
초록· 키워드
오류제보하기
Long-acting injectable (LAI) antipsychotics are useful in the treatments for schizophrenic patients with poor adherence due to their maintaining feature of therapeutic plasma level without daily administrations. However, their long-lasting property can cause complicated problems such as a long-lasting side effect. We report a patient who experienced LAI-induced extrapyramidal symptoms (EPSs) for 5 months after a single injection. During that period, every trial to ameliorate this condition turned out to be a failure. The 3-month formulation of paliperidone palmitate is now close at hand. We have to be aware of possible long-lasting adverse events and confirm the tolerability to LAI before use.
목차
등록된 정보가 없습니다.
참고문헌 (18)
참고문헌 신청
Ereshefsky L / 1984 / Future of depot neuroleptic therapy : pharmacokinetic and pharmacodynamic approaches / J Clin Psychiatry 45:50~59
Brissos S / 2014 / The role of long-acting injectable antipsychotics in schizophrenia : a critical appraisal / Ther Adv Psychopharmacol 4:198~219
Schreiner A / 2015 / Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia / Schizophr Res 169:393~399
Li H / 2015 / Efficacy and safety of oncemonthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an openlabel, prospective, noncomparative study / Neuropsychiatr Dis Treat 12:15~24
Kramer M / 2010 / Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study / Int J Neuropsychopharmacol 13:635~647
Brissos S / 2014 / The role of long-acting injectable antipsychotics in schizophrenia : a critical appraisal / Ther Adv Psychopharmacol 4:198~219
Schreiner A / 2015 / Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia / Schizophr Res 169:393~399
Li H / 2015 / Efficacy and safety of oncemonthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an openlabel, prospective, noncomparative study / Neuropsychiatr Dis Treat 12:15~24
Kramer M / 2010 / Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study / Int J Neuropsychopharmacol 13:635~647
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
항정신병약물 치료 후 인지기능 변화 차이 연구 : 장기 지속형 주사제와경구제 비교의 예비 연구
대한조현병학회지
2018 .01
-
Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
Clinical Psychopharmacology and Neuroscience
2023 .02
-
Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report
Clinical Psychopharmacology and Neuroscience
2017 .01
-
A Case of Ileus in a Patient with Schizophrenia Under Paliperidone Palmitate Treatment
PSYCHIATRY INVESTIGATION
2016 .01
-
팔리페리돈 장기지속형주사제의약물 순응도와 치료 효과
신경정신의학
2015 .01
-
A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder
Clinical Psychopharmacology and Neuroscience
2015 .01
-
The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study
Clinical Psychopharmacology and Neuroscience
2019 .01
-
Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea
Clinical Psychopharmacology and Neuroscience
2020 .01
-
팔리페리돈 장기지속형 주사제 중단에 영향을 미치는 인자
생물치료정신의학
2017 .10
-
Paliperidone Palmitate-induced Urinary Incontinence: A Case Report
Clinical Psychopharmacology and Neuroscience
2016 .01
-
Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis
Clinical Psychopharmacology and Neuroscience
2018 .01
-
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
Clinical Psychopharmacology and Neuroscience
2021 .08
-
Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial
Clinical Psychopharmacology and Neuroscience
2016 .01
-
조현병 환자에서 비전형항정신병약물 사용시 대사지표에 미치는 영향 조사 : 3년 추적연구
대한조현병학회지
2017 .04
-
‘2019 한국형 조현병 약물치료 지침서’에 따른 조현병에서 동반증상 및 부작용의 치료
대한조현병학회지
2019 .01
-
Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia
Clinical Psychopharmacology and Neuroscience
2023 .02
-
Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
Clinical Psychopharmacology and Neuroscience
2017 .01
-
장기지속형 항정신병약물의 임상 실제
신경정신의학
2019 .01
-
돌파정신병과 항정신병약물 장기지속형 주사제
대한조현병학회지
2023 .04
-
항정신병 약물의 병용요법을 사용 중인 환자들에서 아리피프라졸 장기 지속형 주사제의 효능
생물치료정신의학
2024 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0